AAAAAA
Results:
1-15
|
Results: 15
Authors:
Fishbein, I
Chorny, M
Banai, S
Levitzki, A
Danenberg, HD
Gao, JC
Chen, X
Moerman, E
Gati, I
Goldwasser, V
Golomb, G
Citation: I. Fishbein et al., Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model, ART THROM V, 21(9), 2001, pp. 1434-1439
Authors:
Hoffman, A
Stepensky, D
Ezra, A
Van Gelder, JM
Golomb, G
Citation: A. Hoffman et al., Mode of administration-dependent pharmacokinetics of bisphosphonates and bioavailability determination, INT J PHARM, 220(1-2), 2001, pp. 1-11
Authors:
Chen, R
Schlossman, A
Breuer, E
Hagele, G
Tillmann, C
Van Gelder, JM
Golomb, G
Citation: R. Chen et al., Long-chain functional bisphosphonates: Synthesis, anticalcification, and antiresorption activity, HETEROAT CH, 11(7), 2000, pp. 470-479
Authors:
Cohen, H
Levy, RJ
Gao, J
Fishbein, I
Kousaev, V
Sosnowski, S
Slomkowski, S
Golomb, G
Citation: H. Cohen et al., Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles, GENE THER, 7(22), 2000, pp. 1896-1905
Authors:
Chorny, M
Fishbein, I
Golomb, G
Citation: M. Chorny et al., Drug delivery systems for the treatment of restenosis, CR R THER, 17(3), 2000, pp. 249-284
Authors:
Fishbein, I
Chorny, M
Golomb, G
Citation: I. Fishbein et al., Treatment of restenosis by controlled-release delivery systems of tyrphostins, DRUG DEV R, 50(3-4), 2000, pp. 487-496
Authors:
Ezra, A
Golomb, G
Citation: A. Ezra et G. Golomb, Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption, ADV DRUG DE, 42(3), 2000, pp. 175-195
Authors:
Fishbein, I
Chorny, M
Rabinovich, L
Banai, S
Gati, I
Golomb, G
Citation: I. Fishbein et al., Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis, J CONTR REL, 65(1-2), 2000, pp. 221-229
Authors:
Yaffe, A
Golomb, G
Breuer, E
Binderman, I
Citation: A. Yaffe et al., The effect of topical delivery of novel bisacylphosphonates in reducing alveolar bone loss in the rat model, J PERIODONT, 71(10), 2000, pp. 1607-1612
Authors:
Ezra, A
Hoffman, A
Breuer, E
Alferiev, IS
Monkkonen, J
El Hanany-Rozen, N
Weiss, G
Stepensky, D
Gati, I
Cohen, H
Tormalehto, S
Amidon, GL
Golomb, G
Citation: A. Ezra et al., A peptide prodrug approach for improving bisphosphonate oral absorption, J MED CHEM, 43(20), 2000, pp. 3641-3652
Authors:
Cohen, H
Alferiev, IS
Monkkonen, J
Seibel, MJ
Pinto, T
Ezra, A
Solomon, V
Stepensky, D
Sagi, H
Ornoy, A
Patlas, N
Hagele, G
Hoffman, A
Breuer, E
Golomb, G
Citation: H. Cohen et al., Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1) - A novel bisphosphonate, PHARM RES, 16(9), 1999, pp. 1399-1406
Authors:
Teomim, D
Fishbien, I
Golomb, G
Orloff, L
Mayberg, M
Domb, AJ
Citation: D. Teomim et al., Perivascular delivery of heparin for the reduction of smooth muscle cell proliferation after endothelial injury, J CONTR REL, 60(1), 1999, pp. 129-142
Authors:
Patlas, N
Golomb, G
Yaffe, P
Pinto, T
Breuer, E
Ornoy, A
Citation: N. Patlas et al., Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats, TERATOLOGY, 60(2), 1999, pp. 68-73
Authors:
Yaffe, A
Binderman, I
Breuer, E
Pinto, T
Golomb, G
Citation: A. Yaffe et al., Disposition of alendronate following local delivery in a rat jaw, J PERIODONT, 70(8), 1999, pp. 893-895
Authors:
Mathew, M
Fowler, BO
Breuer, E
Golomb, G
Alferiev, IS
Eidelman, N
Citation: M. Mathew et al., Synthesis, characterization, and crystal structure of dicalcium glutarylbis (phosphonate) dihydrate: A covalently pillared layer structure with the potential for epitaxial growth on hydroxyapatite, INORG CHEM, 37(25), 1998, pp. 6485-6494
Risultati:
1-15
|